Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2026)

Beta Bionics' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at $21.8 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 112.19% year-over-year to $21.8 million; the TTM figure through Mar 2026 stood at $38.2 million (up 120.06% YoY), while the FY2025 annual figure was -$162.8 million, down 4583.69% from the prior year.
• Cash from Investing Activities came in at $21.8 million for Q1 2026 at Beta Bionics, up from $658000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $21.8 million in Q1 2026 to a low of -$179.1 million in Q1 2025.
• A 3-year average of -$16.0 million and a median of $6.2 million in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities plunged 2443.3% in 2025 and soared 112.19% in 2026, its largest moves.
• Beta Bionics' Cash from Investing Activities stood at -$29.7 million in 2024, then soared by 102.22% to $658000.0 in 2025, then surged by 3219.0% to $21.8 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $21.8 million, $658000.0, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison